EORTC-1607-GITCG/ABC-09: Open-label first-line, single-arm phase II study of CisGem combined with pembrolizumab in patients with advanced or metastatic biliary tract cancer
Authors 0
- Author list not loaded yet.
Cited by 0 stored of 0
References 1
1 result